Download presentation
Presentation is loading. Please wait.
Published byVirginia Reeves Modified over 9 years ago
1
Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54
2
Effects of simvastatin allocation on first major coronary event, stroke, or revascularization in participants presenting with or without peripheral artery disease Heart Protection Study Group J Vasc Surg 2007;45:645-54
3
Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54
4
Effects of simvastatin allocation on major vascular events in prior disease subgroups Heart Protection Study Group J Vasc Surg 2007;45:645-54
5
Effects of simvastatin allocation on first major vascular event in participants with or without PAD subdivided by other presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54
6
Effects of simvastatin allocation on first and all major vascular events in participants with or without PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54
7
Effects of simvastatin allocation on first peripheral vascular event subdivided by presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54
8
Average use of statin (study or non-study), and average plasma LDL cholesterol concentrations, during follow-up. Table online only Heart Protection Study Group J Vasc Surg 2007;45:645-54
9
DISCUSSION Heart Protection Study Group J Vasc Surg 2007;45:645-54
10
INVITED COMMENTARY William R. Hiatt Heart Protection Study Group J Vasc Surg 2007;45:645-54
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.